Centaur Pharmaceuticals' Acquisition

Centaur Pharmaceuticals was acquired by acquirer and Renovis on December 05, 2002.

Centaur Pharmaceuticals developed a class of small molecule pharmaceutical compounds for the treatment of neurodegenerative and inflammatory diseases such as acute stroke, dementia, rheumatoid arthrit…

Articles about Centaur Pharmaceuticals' Acquisition: